HPIV3 vaccine candidate

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HPIV3 vaccine candidate, covering 2014-12-03 to 2014-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children [Phase 1]

See pricing